| 0.5 |
1.5 |
GO:0009107 |
lipoate biosynthetic process(GO:0009107) |
| 0.5 |
2.0 |
GO:0072180 |
mesonephric duct morphogenesis(GO:0072180) |
| 0.4 |
1.2 |
GO:0035408 |
histone H3-T6 phosphorylation(GO:0035408) |
| 0.3 |
0.9 |
GO:0071104 |
response to interleukin-9(GO:0071104) response to interleukin-11(GO:0071105) |
| 0.3 |
0.8 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.2 |
0.7 |
GO:1990170 |
detoxification of cadmium ion(GO:0071585) stress response to cadmium ion(GO:1990170) |
| 0.2 |
1.3 |
GO:0009450 |
gamma-aminobutyric acid catabolic process(GO:0009450) |
| 0.2 |
0.6 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.2 |
0.5 |
GO:0003176 |
aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) notochord formation(GO:0014028) |
| 0.2 |
0.9 |
GO:0003093 |
regulation of glomerular filtration(GO:0003093) glomerular filtration(GO:0003094) renal filtration(GO:0097205) regulation of renal system process(GO:0098801) |
| 0.2 |
0.5 |
GO:0046931 |
pore complex assembly(GO:0046931) |
| 0.2 |
0.7 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.2 |
0.5 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.2 |
0.5 |
GO:0010041 |
response to iron(III) ion(GO:0010041) positive regulation of histone phosphorylation(GO:0033129) response to DDT(GO:0046680) regulation of chromosome condensation(GO:0060623) cellular response to iron ion(GO:0071281) cellular response to iron(III) ion(GO:0071283) |
| 0.2 |
0.8 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 |
0.7 |
GO:0060014 |
granulosa cell differentiation(GO:0060014) |
| 0.1 |
0.4 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
| 0.1 |
1.0 |
GO:0045780 |
positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 0.1 |
0.4 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.1 |
0.9 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.1 |
0.4 |
GO:0009202 |
deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
| 0.1 |
0.4 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 |
0.4 |
GO:0021919 |
BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 0.1 |
0.2 |
GO:0044070 |
regulation of anion transport(GO:0044070) |
| 0.1 |
0.3 |
GO:0021896 |
forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
| 0.1 |
0.6 |
GO:0006562 |
proline catabolic process(GO:0006562) |
| 0.1 |
0.6 |
GO:0043316 |
natural killer cell activation involved in immune response(GO:0002323) cytotoxic T cell degranulation(GO:0043316) natural killer cell degranulation(GO:0043320) |
| 0.1 |
0.5 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.1 |
0.4 |
GO:0034086 |
maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.1 |
0.3 |
GO:0090206 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.1 |
0.5 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.1 |
0.4 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
| 0.1 |
0.6 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.1 |
0.3 |
GO:0051231 |
mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) |
| 0.1 |
0.2 |
GO:0034626 |
fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 |
0.3 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
| 0.1 |
0.2 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.1 |
0.7 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.1 |
0.4 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.1 |
0.5 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.1 |
0.5 |
GO:0035058 |
nonmotile primary cilium assembly(GO:0035058) |
| 0.1 |
0.5 |
GO:0046618 |
drug export(GO:0046618) |
| 0.1 |
0.3 |
GO:0032878 |
regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.1 |
0.8 |
GO:0009650 |
UV protection(GO:0009650) |
| 0.1 |
0.5 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.1 |
0.2 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 0.1 |
0.2 |
GO:0007109 |
obsolete cytokinesis, completion of separation(GO:0007109) protein hexamerization(GO:0034214) |
| 0.1 |
0.3 |
GO:0018352 |
protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.1 |
0.3 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.1 |
0.4 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.1 |
0.2 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 |
0.2 |
GO:0070734 |
histone H3-K27 methylation(GO:0070734) |
| 0.1 |
0.2 |
GO:0035234 |
ectopic germ cell programmed cell death(GO:0035234) |
| 0.1 |
0.4 |
GO:0032057 |
negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.1 |
0.3 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.1 |
0.3 |
GO:0045767 |
obsolete regulation of anti-apoptosis(GO:0045767) |
| 0.1 |
0.6 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.1 |
0.9 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.1 |
0.8 |
GO:0045117 |
azole transport(GO:0045117) histamine transport(GO:0051608) |
| 0.1 |
0.3 |
GO:0010447 |
response to acidic pH(GO:0010447) |
| 0.1 |
0.5 |
GO:0010866 |
regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.1 |
0.1 |
GO:0001977 |
renal system process involved in regulation of blood volume(GO:0001977) |
| 0.1 |
0.3 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.1 |
2.1 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.1 |
0.4 |
GO:0070779 |
D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.1 |
0.2 |
GO:0052805 |
histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
| 0.1 |
0.3 |
GO:0032075 |
positive regulation of nuclease activity(GO:0032075) |
| 0.1 |
0.2 |
GO:0048865 |
stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
| 0.1 |
0.3 |
GO:0050666 |
regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
| 0.1 |
0.3 |
GO:0003070 |
age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) |
| 0.1 |
0.2 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.0 |
0.2 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.0 |
0.3 |
GO:0046874 |
quinolinate metabolic process(GO:0046874) |
| 0.0 |
0.2 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.0 |
0.2 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.0 |
0.6 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.0 |
0.2 |
GO:0051294 |
establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
| 0.0 |
0.2 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.0 |
0.1 |
GO:0006740 |
glyoxylate cycle(GO:0006097) NADPH regeneration(GO:0006740) |
| 0.0 |
0.1 |
GO:0007231 |
osmosensory signaling pathway(GO:0007231) |
| 0.0 |
1.0 |
GO:0031055 |
DNA replication-independent nucleosome assembly(GO:0006336) chromatin remodeling at centromere(GO:0031055) CENP-A containing nucleosome assembly(GO:0034080) DNA replication-independent nucleosome organization(GO:0034724) CENP-A containing chromatin organization(GO:0061641) |
| 0.0 |
0.3 |
GO:0051383 |
kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
| 0.0 |
0.1 |
GO:0002025 |
vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.0 |
0.3 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 |
0.4 |
GO:0046835 |
carbohydrate phosphorylation(GO:0046835) |
| 0.0 |
0.1 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.0 |
0.2 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.0 |
0.2 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.0 |
0.2 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.0 |
0.2 |
GO:0044818 |
mitotic G2/M transition checkpoint(GO:0044818) |
| 0.0 |
0.6 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.0 |
0.4 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) |
| 0.0 |
0.3 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.0 |
0.4 |
GO:0031622 |
regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) regulation of heat generation(GO:0031650) positive regulation of heat generation(GO:0031652) |
| 0.0 |
0.3 |
GO:0007199 |
G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
| 0.0 |
0.2 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 0.0 |
0.2 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.0 |
0.1 |
GO:0006188 |
IMP biosynthetic process(GO:0006188) IMP metabolic process(GO:0046040) |
| 0.0 |
0.3 |
GO:0045008 |
depyrimidination(GO:0045008) |
| 0.0 |
0.3 |
GO:0043457 |
regulation of cellular respiration(GO:0043457) |
| 0.0 |
0.5 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.0 |
0.8 |
GO:0000291 |
nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.0 |
0.0 |
GO:0033002 |
muscle cell proliferation(GO:0033002) smooth muscle cell proliferation(GO:0048659) |
| 0.0 |
0.1 |
GO:0003011 |
diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
| 0.0 |
0.6 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.0 |
0.1 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.0 |
0.5 |
GO:0015939 |
pantothenate metabolic process(GO:0015939) |
| 0.0 |
0.2 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.0 |
0.1 |
GO:0042560 |
10-formyltetrahydrofolate metabolic process(GO:0009256) 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.0 |
0.1 |
GO:0021759 |
globus pallidus development(GO:0021759) menarche(GO:0042696) |
| 0.0 |
0.3 |
GO:0000959 |
mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
| 0.0 |
0.2 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.0 |
0.1 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.0 |
0.1 |
GO:0009221 |
pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
| 0.0 |
0.3 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.0 |
0.2 |
GO:0051589 |
negative regulation of neurotransmitter transport(GO:0051589) |
| 0.0 |
1.0 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.0 |
0.1 |
GO:0048619 |
embryonic hindgut morphogenesis(GO:0048619) |
| 0.0 |
0.2 |
GO:0045040 |
outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
| 0.0 |
1.2 |
GO:0006611 |
protein export from nucleus(GO:0006611) |
| 0.0 |
0.1 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.0 |
0.1 |
GO:0019448 |
cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) taurine metabolic process(GO:0019530) L-cysteine metabolic process(GO:0046439) |
| 0.0 |
0.7 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.0 |
0.1 |
GO:0071109 |
superior temporal gyrus development(GO:0071109) |
| 0.0 |
0.1 |
GO:0010535 |
regulation of activation of JAK2 kinase activity(GO:0010534) positive regulation of activation of JAK2 kinase activity(GO:0010535) |
| 0.0 |
0.1 |
GO:0006998 |
nuclear envelope organization(GO:0006998) |
| 0.0 |
0.4 |
GO:0007035 |
vacuolar acidification(GO:0007035) |
| 0.0 |
0.4 |
GO:0097031 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 |
0.1 |
GO:0046604 |
regulation of mitotic centrosome separation(GO:0046602) positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.0 |
0.2 |
GO:0007080 |
mitotic metaphase plate congression(GO:0007080) |
| 0.0 |
0.1 |
GO:0061198 |
fungiform papilla development(GO:0061196) fungiform papilla morphogenesis(GO:0061197) fungiform papilla formation(GO:0061198) |
| 0.0 |
0.2 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
| 0.0 |
0.1 |
GO:0050917 |
sensory perception of umami taste(GO:0050917) |
| 0.0 |
0.2 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.0 |
0.6 |
GO:0051923 |
sulfation(GO:0051923) |
| 0.0 |
0.1 |
GO:0060744 |
thelarche(GO:0042695) development of secondary female sexual characteristics(GO:0046543) mammary gland branching involved in thelarche(GO:0060744) |
| 0.0 |
0.3 |
GO:0006400 |
tRNA modification(GO:0006400) |
| 0.0 |
0.1 |
GO:0071428 |
rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
| 0.0 |
0.1 |
GO:0009304 |
tRNA transcription(GO:0009304) 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.0 |
0.1 |
GO:0006679 |
glucosylceramide metabolic process(GO:0006678) glucosylceramide biosynthetic process(GO:0006679) |
| 0.0 |
0.4 |
GO:0035036 |
binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.0 |
0.1 |
GO:0001660 |
fever generation(GO:0001660) |
| 0.0 |
0.3 |
GO:0043097 |
pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.0 |
0.2 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.0 |
0.0 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
| 0.0 |
0.1 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.0 |
0.3 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
0.2 |
GO:0042535 |
positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.0 |
0.1 |
GO:0002726 |
positive regulation of T cell cytokine production(GO:0002726) |
| 0.0 |
0.1 |
GO:0046855 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.0 |
0.3 |
GO:0007498 |
mesoderm development(GO:0007498) |
| 0.0 |
0.6 |
GO:0007067 |
mitotic nuclear division(GO:0007067) |
| 0.0 |
0.7 |
GO:0030325 |
adrenal gland development(GO:0030325) |
| 0.0 |
0.2 |
GO:0010452 |
histone H3-K36 methylation(GO:0010452) |
| 0.0 |
0.4 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.0 |
0.1 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.0 |
0.1 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.0 |
0.1 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.0 |
0.1 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.0 |
0.1 |
GO:0043371 |
negative regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043371) negative regulation of T-helper cell differentiation(GO:0045623) negative regulation of CD4-positive, alpha-beta T cell activation(GO:2000515) |
| 0.0 |
1.3 |
GO:0000236 |
mitotic prometaphase(GO:0000236) |
| 0.0 |
0.1 |
GO:0070498 |
interleukin-1-mediated signaling pathway(GO:0070498) |
| 0.0 |
0.2 |
GO:0017121 |
phospholipid scrambling(GO:0017121) |
| 0.0 |
0.1 |
GO:0072106 |
regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
| 0.0 |
0.0 |
GO:0010908 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) positive regulation of epithelial cell proliferation involved in prostate gland development(GO:0060769) hair follicle placode formation(GO:0060789) renal vesicle formation(GO:0072033) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.0 |
0.1 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 0.0 |
0.1 |
GO:0045839 |
negative regulation of mitotic nuclear division(GO:0045839) |
| 0.0 |
0.0 |
GO:0034204 |
lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) regulation of membrane lipid distribution(GO:0097035) |
| 0.0 |
0.5 |
GO:0006626 |
protein targeting to mitochondrion(GO:0006626) |
| 0.0 |
0.3 |
GO:0007597 |
blood coagulation, intrinsic pathway(GO:0007597) |
| 0.0 |
0.1 |
GO:0006658 |
phosphatidylserine metabolic process(GO:0006658) |
| 0.0 |
0.1 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.0 |
0.1 |
GO:0034959 |
neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.0 |
1.9 |
GO:0042254 |
ribosome biogenesis(GO:0042254) |
| 0.0 |
0.2 |
GO:0042354 |
fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.0 |
1.1 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.0 |
0.7 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.0 |
0.2 |
GO:0001885 |
endothelial cell development(GO:0001885) |
| 0.0 |
0.0 |
GO:0007369 |
gastrulation(GO:0007369) |
| 0.0 |
0.3 |
GO:0000380 |
alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.0 |
0.1 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 |
0.3 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.0 |
0.8 |
GO:0006446 |
regulation of translational initiation(GO:0006446) |
| 0.0 |
0.0 |
GO:0010586 |
miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
| 0.0 |
0.5 |
GO:0006383 |
transcription from RNA polymerase III promoter(GO:0006383) |
| 0.0 |
0.1 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.0 |
0.1 |
GO:0050653 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.0 |
0.1 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.0 |
0.1 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 |
0.4 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.0 |
0.0 |
GO:0002385 |
innate immune response in mucosa(GO:0002227) mucosal immune response(GO:0002385) |
| 0.0 |
0.1 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.0 |
0.1 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.0 |
0.1 |
GO:0047496 |
vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
| 0.0 |
0.2 |
GO:0019221 |
cytokine-mediated signaling pathway(GO:0019221) response to cytokine(GO:0034097) |
| 0.0 |
0.1 |
GO:0048892 |
sensory system development(GO:0048880) lateral line nerve development(GO:0048892) lateral line nerve glial cell differentiation(GO:0048895) lateral line system development(GO:0048925) lateral line nerve glial cell development(GO:0048937) iridophore differentiation(GO:0050935) |
| 0.0 |
0.1 |
GO:0008089 |
anterograde axonal transport(GO:0008089) axonal transport(GO:0098930) |
| 0.0 |
0.3 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 0.0 |
0.2 |
GO:0032784 |
regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.0 |
0.0 |
GO:0070781 |
response to biotin(GO:0070781) |
| 0.0 |
0.1 |
GO:0071451 |
removal of superoxide radicals(GO:0019430) cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
| 0.0 |
0.1 |
GO:0060664 |
epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
| 0.0 |
0.4 |
GO:0070830 |
bicellular tight junction assembly(GO:0070830) |
| 0.0 |
0.4 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 0.0 |
0.1 |
GO:0045666 |
positive regulation of neuron differentiation(GO:0045666) |
| 0.0 |
0.1 |
GO:0051571 |
positive regulation of histone H3-K4 methylation(GO:0051571) |
| 0.0 |
0.3 |
GO:0035338 |
long-chain fatty-acyl-CoA metabolic process(GO:0035336) long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.0 |
0.1 |
GO:0015811 |
sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
| 0.0 |
0.1 |
GO:0060438 |
trachea development(GO:0060438) |
| 0.0 |
0.0 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.0 |
0.1 |
GO:0051124 |
synaptic growth at neuromuscular junction(GO:0051124) |
| 0.0 |
0.1 |
GO:0032916 |
transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 0.0 |
0.2 |
GO:0030010 |
establishment of cell polarity(GO:0030010) |
| 0.0 |
0.1 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.0 |
0.0 |
GO:0060259 |
regulation of feeding behavior(GO:0060259) |
| 0.0 |
0.2 |
GO:0032611 |
interleukin-1 beta production(GO:0032611) |
| 0.0 |
0.6 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.0 |
0.0 |
GO:0045338 |
farnesyl diphosphate metabolic process(GO:0045338) |
| 0.0 |
0.1 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
| 0.0 |
0.4 |
GO:0031532 |
actin cytoskeleton reorganization(GO:0031532) |
| 0.0 |
0.1 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
